Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL177556 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL7635615 | 0.96 | — | — | |
| SCHEMBL6862722 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL1953396 | 0.92 | — | — | |
| Methyl Alcohol SCHEMBL8053975 | 0.89 | ALDH1A1 (0.38) | ALDH1A1ALOX15 | |
| SCHEMBL7770611 | 0.89 | ALDH1A1 (0.38) | ALDH1A1ALOX15 | |
| SCHEMBL20888526 | 0.89 | ALDH1A1 (0.38) | ALDH1A1ALOX15 | |
| SCHEMBL22426007 | 0.89 | ALDH1A1 (0.38) | ALDH1A1ALOX15 | |
| SCHEMBL7770608 | 0.89 | ALDH1A1 (0.38) | ALDH1A1ALOX15 | |
| SCHEMBL7770613 | 0.89 | ALDH1A1 (0.38) | ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1051 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122026000-A | Preparation method of high-temperature-resistant crosslinked polystyrene/polyolefin composite lithium battery diaphragm | 深圳科瑞沃科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-12559581-B2 | Ethylene-copolymers and catalyst mixture for making ethylene copolymers | ARLANXEO NETHERLANDS B.V. (NL) | 2026-02-24 | — | — | US | claimed |
| CN-115279804-B | Ethylene copolymers and catalyst mixtures for making ethylene copolymers | 阿朗新科荷兰有限公司 | 2024-03-26 | — | — | CN | claimed |
| US-20230331884-A1 | ETHYLENE-COPOLYMERS AND CATALYST MIXTURE FOR MAKING ETHYLENE COPOLYMERS | ARLANXEO NETHERLANDS B.V. (NL) | 2023-10-19 | — | — | US | claimed |
| EP-4121468-A1 | ETHYLENE-COPOLYMERS AND CATALYST MIXTURE FOR MAKING ETHYLENE COPOLYMERS | Arlanxeo Netherlands B.V. (NL) | 2023-01-25 | — | — | EP | claimed |
| CN-115279804-A | Ethylene copolymers and catalyst mixtures for the production of ethylene copolymers | 阿朗新科荷兰有限公司 | 2022-11-01 | — | — | CN | claimed |
| WO-2021185737-A1 | ETHYLENE-COPOLYMERS AND CATALYST MIXTURE FOR MAKING ETHYLENE COPOLYMERS | ARLANXEO NETHERLANDS B.V. (NL) | 2021-09-23 | — | — | WO | claimed |
| EP-3882283-A1 | ETHYLENE-COPOLYMERS AND CATALYST MIXTURE FOR MAKING ETHYLENE COPOLYMERS | Arlanxeo Netherlands B.V. (NL) | 2021-09-22 | — | — | EP | claimed |
| US-9382344-B2 | Mitigation of catalyst inhibition in olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2016-07-05 | — | — | US | claimed |
| EP-3013867-A1 | MITIGATION OF CATALYST INHIBITION IN OLEFIN POLYMERIZATION | ExxonMobil Chemical Patents Inc. (US) | 2016-05-04 | — | — | EP | claimed |
| US-20050239981-A1 | Phosphorus bridged metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-10-27 | — | — | US | claimed |
| US-20050239980-A1 | Phosphorus substituted metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-10-27 | — | — | US | claimed |
| EP-0889780-B1 | COMPOSITIONS AND METHODS FOR SELECTIVELY CROSS-LINKING FILMS AND IMPROVED FILM ARTICLES RESULTING THEREFROM | CRYOVAC INC (US) | 2004-07-14 | — | — | EP | claimed |
| EP-1346824-A2 | Compositions and methods for selectively cross-linking films and film articles resulting therefrom | Cryovac, Inc. (US) | 2003-09-24 | — | — | EP | claimed |
| EP-0977808-B1 | AMORPHOUS PROPYLENE-POLYENE COPOLYMERS AND COMPOSITIONS THEREOF | DOW CHEMICAL CO (US) | 2002-10-16 | — | — | EP | claimed |
| EP-0977808-A1 | AMORPHOUS PROPYLENE-POLYENE COPOLYMERS AND COMPOSITIONS THEREOF | THE DOW CHEMICAL COMPANY (US) | 2000-02-09 | — | — | EP | claimed |
| US-5993922-A | MULTILAYER FILM CONTAINING AT LEAST ONE LAYER CONTAINING POLYMER CROSSLINKING ENHANCER COMPOSITION WHEREIN EACH OF AT LEAST ONE LAYER IS CROSSLINKED TO A GREATER DEGREE THAN ONE OTHER LAYER; FOOD PACKAGING | CRYOVAC, INC. (US) | 1999-11-30 | — | — | US | claimed |
| WO-1997036741-A9 | COMPOSITIONS AND METHODS FOR SELECTIVELY CROSS-LINKING FILMS AND IMPROVED FILM ARTICLES RESULTING THEREFROM | — | 1998-12-17 | — | — | WO | claimed |
| WO-1998049229-A1 | AMORPHOUS PROPYLENE-POLYENE COPOLYMERS AND COMPOSITIONS THEREOF | THE DOW CHEMICAL COMPANY (US) | 1998-11-05 | — | — | WO | claimed |
| US-5476903-A | Composition containing copolymer of alpha-olefin and polyene with another polyolefin polymerized in presence of prepolymerized catalyst containing said copolymer | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1995-12-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050239981-A1 | Phosphorus bridged metallocene compounds for olefin polymerization | PYM1, ZNF207, POLL | ALDH1A1 4206/4885ALOX15 1010/4885TDP1 3496/4885 |
| US-12559581-B2 | Ethylene-copolymers and catalyst mixture for making ethylene copolymers | EEF1D, COG7, CCND1 | ALDH1A1 3591/4885ALOX15 566/4885TDP1 2608/4885 |
| US-20050239980-A1 | Phosphorus substituted metallocene compounds for olefin polymerization | CCRL2, ARL1, OSBP2 | ALDH1A1 4248/4885ALOX15 2929/4885TDP1 4547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.